C4 Therapeutics (CCCC) Q2 2026 Earnings Report

693 Followers

CCCC Q2 2026 EPS Results

Actual EPS-$0.18

Consensus EPS-$0.23

Beat/MissBeat by +$0.05

One Year Ago EPS-$0.37

Actual Revenue$6.64M

Expected Revenue$4.00M

Beat/MissBeat by +$2.64M

YoY Revenue Growth+2.75%

QuarterQ2 2026

Date08/11/2026

TimeBefore Open

Conference CallTuesday, August 11, 2026

CCCC Upcoming Earnings

C4 Therapeutics's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.20 / -	-0.44	―
Aug 11, 2026	2026 (Q2)	-0.23 / -0.18	-0.37	51.35% (+0.19)
May 12, 2026	2026 (Q1)	-0.25 / -0.20	-0.37	45.95% (+0.17)
Feb 26, 2026	2025 (Q4)	-0.29 / -0.18	-0.49	63.27% (+0.31)
Nov 06, 2025	2025 (Q3)	-0.41 / -0.44	-0.35	-25.71% (-0.09)
Aug 07, 2025	2025 (Q2)	-0.38 / -0.37	-0.26	-42.31% (-0.11)
May 07, 2025	2025 (Q1)	-0.44 / -0.37	-0.41	9.76% (+0.04)
Feb 27, 2025	2024 (Q4)	-0.49 / -0.49	-0.68	27.94% (+0.19)
Oct 31, 2024	2024 (Q3)	-0.38 / -0.35	-0.55	36.36% (+0.20)
Aug 01, 2024	2024 (Q2)	-0.36 / -0.26	-0.73	64.38% (+0.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed